AACR 2021: Personalised cancer vaccine given after adjuvant therapy safe, shows early efficacy in multiple tumour types
Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and…
Browsing: personal cancer treatment vaccine
Personal neoantigen vaccine prompts strong anti-tumour response in melanoma patients
A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumour cells has been shown…